We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nu Skin's Q3 Earnings Coming Up: Here's What You Should Know
Read MoreHide Full Article
Nu Skin Enterprises, Inc. (NUS - Free Report) is likely to register a decline in top and bottom lines when it reports third-quarter 2024 earnings on Nov. 7. The Zacks Consensus Estimate for revenues is pegged at $444.1 million, suggesting a decrease of nearly 11% from the prior-year quarter’s reported figure. The consensus mark for earnings has remained unchanged in the past 30 days at 20 cents per share, indicating a decline of 64.3% from the figure reported in the year-ago quarter. NUS has a trailing four-quarter earnings surprise of 27.9%, on average.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
Things to Consider Ahead of NUS’ Upcoming Results
Nu Skin has been battling macroeconomic obstacles, which lingered in the second quarter of 2024. The company’s performance was hurt by macroeconomic headwinds across most regions, which weighed on consumer spending and customer acquisition, especially for premium products. The company also grapples with pressures in the direct selling industry.
These headwinds, along with foreign adverse currency fluctuations, raise concerns about the quarter to be reported. For the third quarter of 2024, the company expects revenues between $430 million and $465 million, which suggests a decline of 14% to 7% from the year-ago quarter’s reported level. The company expects adjusted earnings of 15-25 cents a share in the third quarter.
However, Nu Skin’s Rhyz business has been performing well. A focus on innovation, brand building and cost management has been aiding. Nu Skin has also been gaining from its key strategic pillars, Products, Programs and Platforms.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Our proven model doesn’t conclusively predict an earnings beat for Nu Skin this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.
Nu Skin has an Earnings ESP of 0.00% and carries a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Some Stocks With Favorable Combination
Here are some companies worth considering, as our model shows that these have the correct combination to beat on earnings this time around.
Ollie's Bargain Outlet Holdings, Inc. (OLLI - Free Report) currently has an Earnings ESP of +1.50% and a Zacks Rank of 3. OLLI's top line is anticipated to increase year over year when it reports third-quarter fiscal 2024 results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $519 million, which implies 8.1% growth from the year-ago quarter’s reported figure. You can see the complete list of today’s Zacks #1 Rank stocks here.
The company is expected to register an increase in the bottom line. The consensus estimate for Ollie's Bargain’s third-quarter earnings is pegged at 57 cents per share, indicating 11.8% growth from the year-ago quarter. OLLI has a trailing four-quarter earnings surprise of 7.9%, on average.
Sweetgreen, Inc. (SG - Free Report) currently has an Earnings ESP of +4.76% and a Zacks Rank of 3. SG is likely to register growth in its top and bottom lines when it reports third-quarter 2024 results. The Zacks Consensus Estimate for Sweetgreen’s quarterly revenues is pegged at $173.7 million, which indicates an increase of 13.2% from the figure reported in the prior-year quarter.
The consensus estimate for SG’s bottom line is expected to increase 27.3% from the year-ago quarter’s number. Sweetgreen delivered a negative average earnings surprise of almost 12% in the trailing four quarters.
Jack in the Box Inc. (JACK - Free Report) presently has an Earnings ESP of +1.28% and a Zacks Rank of 3. The company is likely to register a top-line decline when it reports fiscal fourth-quarter fiscal 2024 results. The Zacks Consensus Estimate for JACK’s quarterly revenues is pegged at $357.9 million, which indicates a dip of 3.9% from the figure reported in the prior-year quarter.
The consensus estimate for Jack in the Box’s quarterly earnings has declined by 2 cents over the past 30 days to $1.12 per share. The figure indicates growth of 2.8% from the year-ago quarter’s number. JACK delivered an average earnings surprise of 1.7% in the trailing four quarters.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Nu Skin's Q3 Earnings Coming Up: Here's What You Should Know
Nu Skin Enterprises, Inc. (NUS - Free Report) is likely to register a decline in top and bottom lines when it reports third-quarter 2024 earnings on Nov. 7. The Zacks Consensus Estimate for revenues is pegged at $444.1 million, suggesting a decrease of nearly 11% from the prior-year quarter’s reported figure. The consensus mark for earnings has remained unchanged in the past 30 days at 20 cents per share, indicating a decline of 64.3% from the figure reported in the year-ago quarter. NUS has a trailing four-quarter earnings surprise of 27.9%, on average.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
Things to Consider Ahead of NUS’ Upcoming Results
Nu Skin has been battling macroeconomic obstacles, which lingered in the second quarter of 2024. The company’s performance was hurt by macroeconomic headwinds across most regions, which weighed on consumer spending and customer acquisition, especially for premium products. The company also grapples with pressures in the direct selling industry.
These headwinds, along with foreign adverse currency fluctuations, raise concerns about the quarter to be reported. For the third quarter of 2024, the company expects revenues between $430 million and $465 million, which suggests a decline of 14% to 7% from the year-ago quarter’s reported level. The company expects adjusted earnings of 15-25 cents a share in the third quarter.
However, Nu Skin’s Rhyz business has been performing well. A focus on innovation, brand building and cost management has been aiding. Nu Skin has also been gaining from its key strategic pillars, Products, Programs and Platforms.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin Enterprises, Inc. price-consensus-eps-surprise-chart | Nu Skin Enterprises, Inc. Quote
Earnings Whispers for NUS
Our proven model doesn’t conclusively predict an earnings beat for Nu Skin this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.
Nu Skin has an Earnings ESP of 0.00% and carries a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Some Stocks With Favorable Combination
Here are some companies worth considering, as our model shows that these have the correct combination to beat on earnings this time around.
Ollie's Bargain Outlet Holdings, Inc. (OLLI - Free Report) currently has an Earnings ESP of +1.50% and a Zacks Rank of 3. OLLI's top line is anticipated to increase year over year when it reports third-quarter fiscal 2024 results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $519 million, which implies 8.1% growth from the year-ago quarter’s reported figure. You can see the complete list of today’s Zacks #1 Rank stocks here.
The company is expected to register an increase in the bottom line. The consensus estimate for Ollie's Bargain’s third-quarter earnings is pegged at 57 cents per share, indicating 11.8% growth from the year-ago quarter. OLLI has a trailing four-quarter earnings surprise of 7.9%, on average.
Sweetgreen, Inc. (SG - Free Report) currently has an Earnings ESP of +4.76% and a Zacks Rank of 3. SG is likely to register growth in its top and bottom lines when it reports third-quarter 2024 results. The Zacks Consensus Estimate for Sweetgreen’s quarterly revenues is pegged at $173.7 million, which indicates an increase of 13.2% from the figure reported in the prior-year quarter.
The consensus estimate for SG’s bottom line is expected to increase 27.3% from the year-ago quarter’s number. Sweetgreen delivered a negative average earnings surprise of almost 12% in the trailing four quarters.
Jack in the Box Inc. (JACK - Free Report) presently has an Earnings ESP of +1.28% and a Zacks Rank of 3. The company is likely to register a top-line decline when it reports fiscal fourth-quarter fiscal 2024 results. The Zacks Consensus Estimate for JACK’s quarterly revenues is pegged at $357.9 million, which indicates a dip of 3.9% from the figure reported in the prior-year quarter.
The consensus estimate for Jack in the Box’s quarterly earnings has declined by 2 cents over the past 30 days to $1.12 per share. The figure indicates growth of 2.8% from the year-ago quarter’s number. JACK delivered an average earnings surprise of 1.7% in the trailing four quarters.